In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant <i>Helicobacter pylori</i> Strains.

Cancers (Basel) · 2019 · PMC6406402 · PMID 30781380

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantp < 0.0000not a probability at all

Differences in the number of spiral forms between the control and samples treated with 3-BP were statistically significant in a 1 h incubation ( p < 0.05) and highly significant for all time points starting from the 2 h incubation ( p < 0.0000).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.